MOS

Mosaic is a scale, low-cost producer in crop nutrients, anchored by integrated potash and phosphate assets plus a distribution footprint that helps it place volumes through cycles. The core moat is cost position and logistics rather than brand, so returns are highly tied to global nutrient prices and input costs. The more differentiated angle is Brazil, where Mosaic has been highlighting outsized profitability improvement, and a longer-dated option in rare earth recovery from phosphogypsum at its Uberaba site via work with Rainbow Rare Earths.

Financially, current profitability is modest versus prior peaks: trailing revenue is about $12.05B with net margin around 4.5%, ROE about 4.8%, and diluted EPS about $1.70 on some sources, while Q4 2025 was affected by charges and weak volumes. Liquidity is not abundant (cash roughly $277M recently cited), and working-capital swings can dominate near-term free cash flow in downcycles. Valuation looks undemanding if mid-cycle earnings normalize: the stock is about $25.27 (market cap ~$11.0B) and trades at ~9x P/E on current quotes, versus third-party mentions of mid-teens multiples.

Over the next 12 months, the thesis is mean reversion plus execution: improving operating rates, cost-down, and any recovery in potash/phosphate pricing could lift EBITDA meaningfully. Catalysts include delivery against 2026 production targets (about 9M tonnes potash and at least 7M tonnes phosphate) and stabilization in Brazil credit/demand, while key risks are sulfur and other input-cost spikes compressing phosphate margins and further inventory/volume weakness. The rare earth initiative is strategically interesting but unlikely to matter to 12-month earnings.

Recommendation: HOLD. The valuation is already attractive, but the setup still depends on cyclical price recovery and cleaner cash generation after a weak, charge-impacted period.